Allergan (pre Actavis) | Evaluate

Synergy relaxes with positive constipation data

Allergan’s $2bn Kythera takeout is a short sharp shock

January 30, 2015

He who would Valeant be

January 07, 2015

2014 another growth year as big cap stocks hold up

November 18, 2014

Allergan gets its happyish ending

November 07, 2014

Salix ruins its reputation with disastrous inventory admissions

November 03, 2014

Molecular Partners’ second try at floating in Europe’s tepid waters

October 16, 2014

Shabbvie is dead; long live Shire

October 15, 2014

Shabbvie marks difference between great and exceptional deal quarter

October 15, 2014

AbbVie-Shire pact wobbles as inversion backlash spreads

October 03, 2014

Nine months into 2014, big drug stocks post strong performance

Load More